Canada Pension Plan Investment Board
KERX

Canada Pension Plan Investment Board’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-700
Closed -$3K – 1196
2016
Q1 		$3K Sell
700
-1,300
-65% -$5.19K ﹤0.01% 1195
2015
Q4 		$10K Buy
+2,000
New +$9.5K ﹤0.01% 1207
2014
Q2 		– Sell
-1,100
Closed -$19K – 1337
2014
Q1 		$19K Buy
+1,100
New +$16.6K ﹤0.01% 1243

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Canada Pension Plan Investment Board's KERX Position: Q2 2016 in Review

Canada Pension Plan Investment Board sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2016, closing a stake of 700 shares — an estimated $3K sold.

Canada Pension Plan Investment Board first reported a position in KERX in Q1 2014 and held it in 3 quarters. The position peaked at $19K in Q1 2014. 118 funds tracked by Wall St. Rank hold KERX as of Q2 2016.

  • Canada Pension Plan Investment Board reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 700 Keryx Biopharmaceuticals Inc shares in Q2 2016, an estimated $3K.
  • Canada Pension Plan Investment Board first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Keryx Biopharmaceuticals Inc position peaked at $19K in Q1 2014.
  • 118 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2016.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2016, filed 11 Aug 2016.